Adagene

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adagene and other ETFs, options, and stocks.

About ADAG

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.

CEO

Pei Zhi Luo

CEOPei Zhi Luo

Employees

259

Employees259

Headquarters

Suzhou, Jiangsu

HeadquartersSuzhou, Jiangsu

Founded

2011

Founded2011

Employees

259

Employees259

ADAG Key Statistics

Market cap

55.62M

Market cap55.62M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

31.30K

Average volume31.30K

High today

$1.32

High today$1.32

Low today

$1.25

Low today$1.25

Open price

$1.25

Open price$1.25

Volume

3.75K

Volume3.75K

52 Week high

$14.50

52 Week high$14.50

52 Week low

$1.22

52 Week low$1.22

ADAG Earnings

-$1.36

-$0.91

-$0.45

$0.00

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Estimated— per share

Actual

-$1.36 per share

Actual-$1.36 per share

Adagene

Why Robinhood?

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. Show more

ADAG Key Statistics

Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody.